United Kingdom· GB-APID-42097311000001103
Quviviq 50mg tablets
A daridorexant product containing daridorexant, registered in United Kingdom by Idorsia Pharmaceuticals UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Daridorexant is registered in 15 of 19 countries.
Countries holding a registration under ATC N05CJ03 (daridorexant), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Daridorexant · ATC N05CJ03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of daridorexant costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Daridorexant · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- FR France$3.24
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Daridorexant
- Manufacturer
- Idorsia Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N05CJ03
- ATC class
- Daridorexant
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07649993895021
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Daridorexant in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaQUVIVIQIDORSIA PHARMACEUTICALS LTD
- NorwayQuviviqIdorsia
- CzechiaQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH, Lörrach
- SwitzerlandQUVIVIQ 25 mg , FilmtablettenIdorsia Pharmaceuticals Ltd
- FinlandQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH
- BelgiumQuviviq 25 mgIdorsia Pharmaceuticals Deutschland
- SpainQUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAIdorsia Pharmaceuticals Deutschland Gmbh
- PolandQUVIVIQIdorsia Pharmaceuticals Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Quviviq
- Liechtenstein · Quviviq
- Norway · Quviviq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/385e7c56-7c40-477c-a9aa-d9bd925678b7 GET /v1/drugs/385e7c56-7c40-477c-a9aa-d9bd925678b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42097311000001103",
"desc": "Quviviq 50mg tablets (Idorsia Pharmaceuticals UK Ltd)",
"form": "Oral tablet",
"vpid": "42235211000001104",
"source": "dmd",
"vtm_id": "42222711000001100",
"strength": "50 mg",
"substance": "Daridorexant",
"ingredient": "Daridorexant hydrochloride",
"supplier_code": "41621911000001105"
}See everything about daridorexant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.